Company intelligence / Profile preview

Enfotrace

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

EnfoTrace was a specialized technology company providing GPS-based tracking and risk mitigation solutions for high-value assets, with a significant presence in the healthcare and automotive finance sectors. In the life sciences industry, the company's technology was utilized for medical device tracking and ensuring compliance with Unique Device Identification (UDI) regulations. By providing real-time visibility into the location and status of mobile medical resources, EnfoTrace helped healthcare organizations improve supply chain efficiency and patient safety. The company was acquired in 2011 by Bertram Capital and merged with ProconGPS to form Spireon, where its technology continues to support mobile resource management.

Modalities: Device
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Enfotrace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enfotrace.

Explore the full profile